NEUTRINO DEVELOPMENT CORP. v. Sonosite, Inc.

423 F. Supp. 2d 673, 2006 U.S. Dist. LEXIS 23316, 2006 WL 734421
Procedural entryThis page is a short order in NEUTRINO DEVELOPMENT CORP. v. Sonosite, Inc.. Read the opinion of the Court — 410 F. Supp. 2d 529
District Court, S.D. Texas·Decided March 21, 2006·No. Civ.A. H-01-2484·Published

Opinion

MEMORANDUM AND ORDER

RAINEY, District Judge.

Pending before the Court is Defendant’s Motion for Summary Judgment of Invalidity Based on New Matter (Dkt.# 279). The Court, after reviewing the motion, the responses of the parties and the relevant law, is of the opinion that the motion should be GRANTED.

Factual and Procedural Background

This is an action for patent infringement brought by Neutrino Development Corporation (“Neutrino”) against Sonosite, Inc. (“Sonosite”). Neutrino is the owner of United States Patent No. 6,221,021 (“the ’021 patent”). Neutrino alleges that four devices manufactured and marketed by Sonosite, the Sonosite 180, SonoHeart, Sonosite 180 PLUS, and the SonoHeart PLUS, infringe on the ’021 patent.

The ’021 patent application was filed on May 30, 1999, and claimed priority to an earlier patent application, Application Serial No. 08/926, 209, filed on September 9, 1997, which was issued as U.S. Patent No. 5,947,901 (“the ’901 patent application” and the “ ’901 patent,” respectively). The ’021 patent application, entitled “Method and Apparatus for Penile Hemodynamic Stimulation, Monitoring, and Drug Delivery Acceleration,” described a device for “stimulating and/or monitoring hemody-namic activity, such as blood flow, in a penis.” U.S. Patent No. 6,221,021 at col. 1,11. 15-16. On February 4, 2000, the U.S. Patent & Trade Office (“PTO”) rejected all of the claims in the original ’021 Patent Application. In May 2000, Redaño amended the pending ’021 patent application. Part of that amendment became the claims of the ’021 patent, which was issued on April 24, 2001.

Defendant Sonosite began as a division of ATL Ultrasound, Inc., and was spun off as a public company in April 1998. Sono-site unveiled its first public product in the realm of hand-carried ultrasound devices, the Sonosite 180, on May 17, 1999. Sono-site began selling the device in June 1999. In January 2000, Sonosite launched its second product, the SonoHeart. In April 2001, Sonosite launched a new generation of these two devices with its introduction of the SonoSite 180 PLUS and the SonoH-eart PLUS.

On July 24, 2001, Neutrino filed this action, alleging that Sonosite had illegally used Redano’s invention and infringed the ’021 patent. Sonosite answered the complaint on August 14, 2001, asserting that the ’021 patent claims are not infringed and are invalid, and counterclaimed for declaratory judgment of non-infringement and invalidity.

On February 20, 2002, after extensive briefing, the Court held a one-day Mark-man hearing on claim construction. On October 9, 2002, the Court stayed all proceedings pending the Court’s Markman and summary judgment rulings. The Court issued its claim construction on August 21, 2003. Subsequently, the Court granted Neutrino’s Motion for Summary Judgment on Infringement (Dkt.# 136) finding that Sonosite’s devices literally infringed the ’021 patent and that the reverse doctrine of equivalents was not applicable (Dkt.# 162).

Summary Judgment Standard

Summary judgment is proper if “the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there *675 is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law.” Fed. R. Crv. P. 56(c); see also Christopher Village, LP v. Retsinas, 190 F.3d 310, 314 (5th Cir. 1999). “For any matter on which the non-movant would bear the burden of proof at trial ..., the movant may merely point to the absence of evidence and thereby shift to the non-movant the burden of demonstrating by competent summary judgment proof that there is an issue of material fact warranting trial.” Transamerica Ins. Co. v. Avenell, 66 F.3d 715, 718-19 (5th Cir. 1995); see also Celotex Corp. v. Catrett, 477 U.S. 317, 323-25, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986). To prevent summary judgment, the non-movant must “respond by setting forth specific facts” that indicate a genuine issue of material fact. Rushing v. Kansas City S. Ry. Co., 185 F.3d 496, 505 (5th Cir.1999).

When considering a motion for summary judgment, the Court must view the evidence in the light most favorable to the non-movant and draw all reasonable inferences in favor of the non-movant. See Samuel v. Holmes, 138 F.3d 173, 176 (5th Cir.1998); Texas v. Thompson, 70 F.3d 390, 392 (5th Cir.1995). “The court may not undertake to evaluate the credibility of the witnesses, weigh the evidence, or resolve factual disputes; so long as the evidence in the record is such that a reasonable jury drawing all inferences in favor of the nonmoving party could arrive at a verdict in that party’s favor, the court must deny the motion.” Int'l Shortstop, Inc. v. Rally’s, Inc., 939 F.2d 1257, 1263 (5th Cir.1991). However, the non-movant cannot avoid summary judgment by presenting only “conclusory allegations,” or “unsubstantiated assertions,” such as the bare allegations of a complaint, but must present sufficient evidenqe, such as sworn testimony in a deposition or affidavit, to create a genuine issue of material fact as to the claim asserted. Little v. Liquid Air Corp., 37 F.3d 1069, 1075 (5th Cir.1994) (en banc).

Patent cases are as amenable to summary judgment as any other case when no genuine issue of material fact exists and the movant is entitled to judgment as a matter of law. See Warner-Jenkinson Co. v. Hilton Davis Chem. Co., 520 U.S. 17, 39, 117 S.Ct. 1040, 137 L.Ed.2d 146 (1997); Johnston v. IVAC Corp., 885 F.2d 1574, 1576-77 (Fed.Cir.1989); SRI Int’l v. Matsushita Elec. Corp. of Am., 775 F.2d 1107, 1116 (Fed.Cir.1985). However, a court should apply a somewhat more exacting scrutiny to a motion for summary judgment based on invalidity because there is a statutory presumption that an issued patent is valid. This presumption “is based in part on the expertise of patent examiners presumed to have done their jobs.” Brooktree Corp. v. Adv. Micro Devices, Inc.,

Free access — add to your briefcase to read the full text and ask questions with AI

NEUTRINO DEVELOPMENT CORP. v. Sonosite, Inc., 423 F. Supp. 2d 673, 2006 U.S. Dist. LEXIS 23316, 2006 WL 734421 (S.D. Tex. 2006).

423 F. Supp. 2d 673 (NEUTRINO DEVELOPMENT CORP. v. Sonosite, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Little v. Liquid Air Corp.
37 F.3d 1069 (Fifth Circuit, 1994)
Transamerica Ins. Co. v. Avenell
66 F.3d 715 (Fifth Circuit, 1995)
Christopher Village, Ltd. Partnership v. Retsinas
190 F.3d 310 (Fifth Circuit, 1999)
Warner-Jenkinson Co. v. Hilton Davis Chemical Co.
520 U.S. 17 (Supreme Court, 1997)
Ralston Purina Company v. Far-Mar-Co, Inc.
772 F.2d 1570 (Federal Circuit, 1985)
Waldemar Link, Gmbh & Co. v. Osteonics Corporation
32 F.3d 556 (Federal Circuit, 1994)
Dr. Raymond G. Tronzo v. Biomet, Inc.
156 F.3d 1154 (Federal Circuit, 1998)
Schering Corporation and Biogen, Inc. v. Amgen Inc.
222 F.3d 1347 (Federal Circuit, 2000)
Purdue Pharma L.P. v. Faulding Inc.
230 F.3d 1320 (Federal Circuit, 2000)
In re Smythe
480 F.2d 1376 (Customs and Patent Appeals, 1973)